Institute for Cancer Research

 

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded.

The Institute has internationally strong research groups within biochemistry, cell and tumor biology, genetics, radiation biology, immunology and cancer prevention. For more than 30 years there has been a close interaction between researchers at the Institute and cancer surgeons, oncologists and pathologists. This emphasis on translational science has resulted in numerous clinical protocols based on in-house research, and the Institute is a key partner in the Comprehensive Cancer Center, organizationally under the Division of Surgery and Cancer Treatment at Oslo University Hospital.

Gunnar Sæter<br>Scientific director
Gunnar Sæter
Scientific director

Scientific production - Institute for Cancer Research

  Publications Doctoral theses
2014 so far  
2013 194 27
2012  184 18
2011 188 22
2010 204 11
2009 175 21
2008 147 11

Department overview

 

Latest news

The next Oslo University Hospital research seminar Oct 6th 14:30

The decade of psychiatry - new knowledge about disease mechanisms and outcome

 

Speakers: professor Ole Andreassen, professor Ingrid Melle, scientist Torill Ueland, researcher Ingrid Dieset, associate professor Unn Haukvik and associate professor Lars T. Westlye, all from Norwegian Centre for Mental Disorders Research (NORMENT), University of Oslo (UiO) and OUH.

Time: Monday, October 6th, 2014, at 14:30-16:00.
Place: Blue Auditorium, Rikshospitalet, Sognsvannsveien 20, Oslo.

 
 

Official opening of the KG Jebsen Colorectal Cancer Research Centre

 
Hans Peter Jebsen and Ragnhild A. Lothe
Hans Peter Jebsen and Ragnhild A. Lothe

The K.G. Jebsen Colorectal Cancer Research Centre was recently officially opened by the chair of the Jebsen Foundation’s board of directors, Hans Peter Jebsen. Prof. Ragnhild A. Lothe will lead the Centre together with the interdisciplinary PI team consisting of Prof. Michael Bretthauer (gastroenterologist), Prof. Arild Nesbakken (surgeon), Prof. Kjell Tveit (oncologist) and ass. Prof. Rolf I. Skotheim (bioinformatician).

This is the only Jebsen Centre in Oslo that has Oslo University Hospital as its main host institution. Prof. Sigbjørn Smeland, head of the hosting Division of Cancer, Surgery and Transplantation, said in his talk that the Centre was an excellent example of how to organise and succeed in translational research within a Comprehensive Cancer Centre.

 
 

Two researchers from Oslo University Hospital among the world's most influential

 
Blomhoff (left) and Kjeldsen
Blomhoff (left) and Kjeldsen

Thomson Reuters - the multinational media and information firm that operates in more than 100 countries, and has more than 60,000 employees around the world - has selected The "World's most influential scientific minds 2014".
They have listed some 3,200 researchers who published the greatest number of highly cited papers in one of 21 broad fields. These highly cited researchers were determined by analyzing at citation data over the last 11 years to identify those who published the highest-impact work (2002—2012 and 2012—2013). These individuals are influencing the future direction of their fields, and of the world.
Seven Norwegian scientists are on the list, and of these two researchers represent Oslo University Hospital. These are Rune Blomhoff from the Department of Clinical Service at the Divsion of Cancer, Surgery and Transplantation and Sverre Kjeldsen from the Department of Cardiology, at the Medical Clinic.

 
 

Oslo University Hospital awarding excellent research

 
From left: Leithe, Sollid and Emblem (photo Ram Gupta)
From left: Leithe, Sollid and Emblem (photo Ram Gupta)

Three scientists recently received awards for their outstandig work at a ceremony taking place at Oslo University Hospital. This is the second year such prizes have been distributed in order to honour excellent scientific work.
The major prize - the "Excellent Researcher Award" - went to professor Ludvig M. Sollid. Edvard Leithe and Kyrre Eeg Emblem both received the "Early Career Award".
The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities.

 
 

OUH researchers first and last authors on New England Journal of Medicine article

 
Løberg (left) and Bretthauer
Løberg (left) and Bretthauer

Magnus Løberg and Michael Bretthauer from the Department of Transplantation Medicine at Oslo University Hospital are first and last author respectively on an article recently published in New Eng J Med (journal impact factor 54.42), entitled "Long-Term Colorectal-Cancer Mortality after Adenoma Removal".
Taking advantage of nationwide data in the Cancer Registry of Norway on patients who have had colorectal adenomas removed, they have evaluated colorectal-cancer mortality in a large, population-based cohort with virtually complete follow-up for death from colorectal cancer.
The findings are commented in an editorial in NEJM.

 
 

UiO's Innovations Prize 2014 to Øyvind S. Bruland

 
Øyvind S. Bruland (photo Ola Sæther)
Øyvind S. Bruland (photo Ola Sæther)

Professor Øyvind S. Bruland, head of the Sarcoma group at the from the Department of Oncology at Oslo University Hospital, has together with Roy Hartwig Larsen won the University of Oslo Innovation Prize for 2014.

Bruland and his research has in this connection been thoroughly presented in UiO's web newspaper "Uniforum" and in UiO's research magazine "Apollon" (download in pdf format).